or Try an Advanced Search...

    Technical Analysis for VRDN - Viridian Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 20.14 -6.93% -1.50
    VRDN closed down 6.93 percent on Friday, November 15, 2024, on 1.11 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical VRDN trend table...
    Date Alert Name Type % Chg
    MACD Bearish Centerline Cross Bearish 0.00%
    Multiple of Ten Bullish Other 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 50 DMA Bearish -6.93%
    Stochastic Reached Oversold Weakness -6.93%
    Oversold Stochastic Weakness -6.93%
    20 DMA Resistance Bearish -10.41%
    Calm After Storm Range Contraction -10.41%
    Older End-of-Day Signals for VRDN ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR 2 days ago
    Down 5% 2 days ago
    Down 3% 2 days ago
    Fell Below Lower Bollinger Band 2 days ago
    Fell Below Previous Day's Low 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    VRDN Chart by TradingView
    Basic chart:

    Profile

    Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado, with research and development operations in Waltham, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Biotechnology Biology Monoclonal Antibody Thyroid Eye Disease

    Is VRDN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Viridian Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Nov 12 Viridian Therapeutics GAAP EPS of -$1.15 misses by $0.08, revenue of $0.09M beats by $0.04M
    Nov 12 Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data
    Oct 31 Viridian Therapeutics Insiders Added US$616.3k Of Stock To Their Holdings
    Oct 23 Viridian Therapeutics' Superior Prospects Make It A Buy
    Sep 26 Forecasting The Future: 13 Analyst Projections For Viridian Therapeutics
    Sep 12 Viridian Therapeutics slides on pricing $225M securities offering
    Sep 12 Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock
    Sep 10 Viridian: Active TED Data Signifies Next Round Of Positive Data On The Way
    Sep 10 Viridian Therapeutics announces proposed underwritten offering
    See more VRDN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.2
    52 Week Low 11.4
    Average Volume 1,657,911
    200-Day Moving Average 17.16
    50-Day Moving Average 22.64
    20-Day Moving Average 23.18
    10-Day Moving Average 23.27
    Average True Range 1.44
    RSI (14) 36.31
    ADX 21.92
    +DI 18.29
    -DI 32.30
    Chandelier Exit (Long, 3 ATRs) 22.89
    Chandelier Exit (Short, 3 ATRs) 23.96
    Upper Bollinger Bands 25.83
    Lower Bollinger Band 20.53
    Percent B (%b) -0.07
    BandWidth 22.86
    MACD Line -0.08
    MACD Signal Line 0.32
    MACD Histogram -0.4055
    Fundamentals Value
    Market Cap 1.2 Billion
    Num Shares 59.7 Million
    EPS -5.14
    Price-to-Earnings (P/E) Ratio -3.92
    Price-to-Sales 3322.96
    Price-to-Book 7.22
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 23.32
    Resistance 3 (R3) 23.51 22.64 22.79
    Resistance 2 (R2) 22.64 21.83 22.55 22.61
    Resistance 1 (R1) 21.39 21.33 20.96 21.20 22.44
    Pivot Point 20.52 20.52 20.30 20.43 20.52
    Support 1 (S1) 19.27 19.71 18.84 19.08 17.84
    Support 2 (S2) 18.40 19.21 18.31 17.67
    Support 3 (S3) 17.15 18.40 17.49
    Support 4 (S4) 16.96